{
  "nct_id": "NCT78883924",
  "indication": "Breast Cancer",
  "phase": "Phase 3",
  "sample_size": 194,
  "duration_weeks": 52,
  "dropout_rate": 0.21,
  "primary_endpoints": [
    "Disease-free survival"
  ],
  "secondary_endpoints": [
    "Objective response rate",
    "Disease-free survival"
  ],
  "blinding": "double-blind",
  "control_arm": "active comparator",
  "outcome_summary": "Study no significant difference compared to placebo.",
  "success": false,
  "failure_reason": "Insufficient efficacy"
}